Related references
Note: Only part of the references are listed.The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
M. Stotz et al.
BRITISH JOURNAL OF CANCER (2014)
Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer
In Rae Cho et al.
GASTRIC CANCER (2014)
Prognostic Value of PLR in Various Cancers: A Meta-Analysis
Xin Zhou et al.
PLOS ONE (2014)
Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
C. Marcelo Diaz-Montero et al.
SEMINARS IN ONCOLOGY (2014)
Transforming Growth Factor-Beta and Matrix Metalloproteinases: Functional Interactions in Tumor Stroma-Infiltrating Myeloid Cells
Jelena Krstic et al.
SCIENTIFIC WORLD JOURNAL (2014)
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
Suee Lee et al.
BMC CANCER (2013)
Increase in CD14+HLA-DR-/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
Fumitaka Arihara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
Ang Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell et al.
LANCET ONCOLOGY (2013)
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
Florian Lordick et al.
LANCET ONCOLOGY (2013)
A Large Cohort Study Reveals the Association of Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio with Favorable Prognosis in Nasopharyngeal Carcinoma
Jing Li et al.
PLOS ONE (2013)
Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
X. Jiang et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
T Cells in Gastric Cancer: Friends or Foes
Amedeo Amedei et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer
Ugo De Giorgi et al.
CLINICAL BREAST CANCER (2012)
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level
Yoo-Young Lee et al.
GYNECOLOGIC ONCOLOGY (2012)
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma
Luis F. Porrata et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Obesity, inflammation, and liver cancer
Beicheng Sun et al.
JOURNAL OF HEPATOLOGY (2012)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
Zhi-Ming Li et al.
PLOS ONE (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
Viren Asher et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Effect of classification based on combination of mutation and methylation in colorectal cancer prognosis
Haruhiko Aoyagi et al.
ONCOLOGY REPORTS (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer
Hideaki Shimada et al.
GASTRIC CANCER (2010)
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Isabelle Ray-Coquard et al.
CANCER RESEARCH (2009)
Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma
Frank A. Sinicrope et al.
GASTROENTEROLOGY (2009)
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
H. E. Lee et al.
BRITISH JOURNAL OF CANCER (2008)
Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer
Giuseppe Perrone et al.
EUROPEAN JOURNAL OF CANCER (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
Junliang Fu et al.
GASTROENTEROLOGY (2007)
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma
Atsushi Sasaki et al.
SURGERY (2006)
Tumor-infiltrating T lymphocytes: friends or foes?
P Yu et al.
LABORATORY INVESTIGATION (2006)
Epidemiology of gastric cancer
Katherine D. Crew et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Role of infiltrated leucocytes in tumour growth and spread
EY Lin et al.
BRITISH JOURNAL OF CANCER (2004)
Lymphocyte counts independently predict overall survival in advanced cancer patients: A biomarker for IL-2 immunotherapy
LA Fumagalli et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Tumor-associated macrophages in breast cancer
RD Leek et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2002)
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
S Sakaguchi et al.
IMMUNOLOGICAL REVIEWS (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)